Bide Pharmatech Co., Ltd. (SHA:688073)

China flag China · Delayed Price · Currency is CNY
47.86
+1.17 (2.51%)
Jul 29, 2026, 4:00 PM EDT
Market Cap4.12B -20.2%
Revenue (ttm)1.35B +18.9%
Net Income167.88M +37.6%
EPS1.93 +41.1%
Shares Out 86.15M
PE Ratio24.75
Forward PEn/a
Dividend1.16 (2.48%)
Ex-Dividend DateJun 10, 2026
Volume2,187,060
Open47.50
Previous Close46.69
Day's Range46.21 - 48.47
52-Week Range43.21 - 82.88
Beta0.50
Analystsn/a
Price Targetn/a
Earnings DateAug 28, 2026

About Bide Pharmatech

Bide Pharmatech Co., Ltd. engages in the research, development, production, and sale of drug molecule building blocks and scientific reagents in China. Its products are used in life sciences, organic chemistry, analytical chemistry, and other applications. Bide Pharmatech Co., Ltd. was founded in 2007 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2007
Employees 734
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688073
Full Company Profile

Financial Performance

In 2025, Bide Pharmatech's revenue was 1.32 billion, an increase of 20.13% compared to the previous year's 1.10 billion. Earnings were 151.74 million, an increase of 29.22%.

Financial Statements